| 发明名称 |
Therapeutic agents |
| 摘要 |
The present invention provides a method of treating and preventing obesity and related co-morbid conditions comprising the administration of a therapeutically effective amount of one or more monoamine reuptake inhibitors which are serotonin reuptake inhibitors and/or noradrenaline reuptake inhibitors and a 5-HT1A agonist to a patient in need thereof.
|
| 申请公布号 |
US2003130355(A1) |
申请公布日期 |
2003.07.10 |
| 申请号 |
US20020204392 |
申请日期 |
2002.11.12 |
| 申请人 |
HEAL DAVID JOHN;CHEETHAM SHARON CRAWFORD |
发明人 |
HEAL DAVID JOHN;CHEETHAM SHARON CRAWFORD |
| 分类号 |
A61K45/00;A61K31/137;A61K31/40;A61K31/495;A61K31/505;A61K45/06;A61P1/16;A61P3/00;A61P3/04;A61P3/06;A61P3/10;A61P9/00;A61P9/12;A61P11/00;A61P15/08;A61P19/02;A61P19/06;A61P29/00;A61P35/00;A61P43/00;(IPC1-7):A61K31/137 |
主分类号 |
A61K45/00 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
